Please login to your online account to display your discounted pricing

anti-Sars Spike Protein, Polyclonal, Novus Biologicals™


Manufacturer: novus biologicals canada  NB10056048

 View more versions of this product

 Disclaimers

For Research Use Only

Catalog No. NB10056048

  • / Each
 

Description & Specifications

Specifications

Primary or Secondary Primary
Monoclonal or Polyclonal Polyclonal
Concentration 0.5mg/mL
Applications ELISA
Applications Western Blotting
Cross Reactivity Virus
Immunogen The antibody was developed by immunizing rabbits with synthetic peptides corresponding to amino acids 288-303 of the putative SARS Spike glycoprotein (Genbank accession no. NP_828851).
Conjugate Unlabeled
Formulation PBS containing 0.2% gelatin
Test Specificity The was tested on a cell line transfected with a partial-length cDNA coding for the N-terminal portion of SARS Spike protein with a predicted molecular weight of 68 kDa. Spike glycoprotein of the human SARS coronavirus.
Antigen Sars Spike Protein
Regulatory Status RUO
Format Purified
Host Species Rabbit
Quantity 0.1mg